Search

Your search keyword '"Rahalkar S"' showing total 1 results
Start Over Author "Rahalkar S" Topic atezolizumab
1 results on '"Rahalkar S"'

1. 1441P Atezolizumab and bevacizumab (atezo + bev) ± radiotherapy (RT) vs docetaxel (doc) in checkpoint inhibitor (CPI)–experienced metastatic NSCLC (mNSCLC): Results from the phase Ib/II MORPHEUS-lung study.

Author

Ghiringhelli, F., Felip, E., Zer, A., Greillier, L., Greystoke, A., Al-Sakaff, N., Helms, H-J., Pintoffl, J.P., Rahalkar, S., Lim, F.L., and Cho, B.C.

Subjects
*ATEZOLIZUMAB, *BEVACIZUMAB, *DOCETAXEL, *NON-small-cell lung carcinoma, *METASTASIS
Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results